LivaNova PLC Amortization of Deferred Charges
LivaNova PLC (LIVN) reported Amortization of Deferred Charges of $2.17 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredCharges · last filed 2021-03-01
- LivaNova PLC amortization of deferred charges for the quarter ending 2019-12-31 was -$686.00K, a 107.44% decline year-over-year.
- LivaNova PLC amortization of deferred charges for the quarter ending 2019-09-30 was $28.00K.
- LivaNova PLC amortization of deferred charges for the quarter ending 2019-06-30 was $1.82M, a 42.83% decline year-over-year.
- LivaNova PLC amortization of deferred charges for the quarter ending 2019-03-31 was $1.41M, a 28.70% decline year-over-year.
- LivaNova PLC amortization of deferred charges for fiscal 2020 was $2.17M, a 15.69% decline from fiscal 2019.
- LivaNova PLC amortization of deferred charges for fiscal 2019 was $2.58M, a 80.74% decline from fiscal 2018.
- LivaNova PLC amortization of deferred charges for fiscal 2018 was $13.37M, a 57.93% decline from fiscal 2017.
- LivaNova PLC amortization of deferred charges for fiscal 2017 was $31.78M, a 22.47% increase from fiscal 2016.
| Period end | Amortization of Deferred Charges 3 month | Amortization of Deferred Charges 6 month | Amortization of Deferred Charges 8 month | Amortization of Deferred Charges 9 month | Amortization of Deferred Charges 12 month | Amortization of Deferred Charges 20 month |
|---|---|---|---|---|---|---|
| 2020-12-31 | $2.17M 10-K · filed 2021-03-01 | |||||
| 2019-12-31 | -$686.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$658.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.16M derived: sum of 3 quarters · filed 2021-03-01 | $2.58M 10-K · filed 2021-03-01 | ||
| 2019-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $1.85M derived: sum of 2 quarters · filed 2019-10-30 | $3.26M 10-Q · filed 2019-10-30 | $12.48M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $3.23M 10-Q · filed 2019-07-31 | $12.45M derived: sum of 3 quarters · filed 2021-03-01 | $11.44M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | $1.41M 10-Q · filed 2019-05-01 | $10.63M derived: sum of 2 quarters · filed 2021-03-01 | $9.62M derived: sum of 3 quarters · filed 2021-03-01 | $12.80M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $9.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $8.20M derived: sum of 2 quarters · filed 2021-03-01 | $11.39M derived: sum of 3 quarters · filed 2021-03-01 | $13.37M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | -$1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $2.18M derived: sum of 2 quarters · filed 2019-10-30 | $4.16M 10-Q · filed 2019-10-30 | $12.11M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | $3.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $5.17M 10-Q · filed 2019-07-31 | $13.12M derived: sum of 3 quarters · filed 2020-03-02 | $19.18M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-03-31 | $1.98M 10-Q · filed 2019-05-01 | $9.93M derived: sum of 2 quarters · filed 2020-03-02 | $15.99M derived: sum of 3 quarters · filed 2020-03-02 | $27.25M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2017-12-31 | $7.95M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $14.01M derived: sum of 2 quarters · filed 2020-03-02 | $25.27M derived: sum of 3 quarters · filed 2020-03-02 | $31.78M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $6.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $17.32M derived: sum of 2 quarters · filed 2018-11-01 | $23.83M 10-Q · filed 2018-11-01 | $32.67M derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2017-06-30 | $11.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $17.77M 10-Q · filed 2018-08-02 | $26.61M derived: sum of 3 quarters · filed 2019-03-18 | $35.07M derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2017-03-31 | $6.51M 10-Q · filed 2018-05-03 | $15.35M derived: sum of 2 quarters · filed 2019-03-18 | $23.81M derived: sum of 3 quarters · filed 2019-03-18 | $28.96M derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2016-12-31 | $8.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $17.30M derived: sum of 2 quarters · filed 2019-03-18 | $22.45M derived: sum of 3 quarters · filed 2019-03-18 | $25.95M 10-K · filed 2019-03-18 | ||
| 2016-09-30 | $8.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $13.61M derived: sum of 2 quarters · filed 2017-11-02 | $17.11M 10-Q · filed 2017-11-02 | |||
| 2016-06-30 | $5.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $8.66M 10-Q · filed 2017-08-09 | ||||
| 2016-03-31 | $3.50M 10-Q · filed 2017-05-03 | |||||
| 2015-12-31 | $12.72M 10-K · filed 2017-03-01 | $12.72M 10-K · filed 2018-02-28 | ||||
| 2015-04-24 | $0.00 10-K · filed 2018-02-28 | |||||
| 2014-04-25 | $0.00 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |